News Focus
News Focus
Followers 1
Posts 23
Boards Moderated 0
Alias Born 03/03/2017

Re: Investor_cmz post# 29933

Thursday, 04/30/2020 10:11:24 AM

Thursday, April 30, 2020 10:11:24 AM

Post# of 35715
Not trying to be combative or bashing but my amateur read of data was that there were 9/10 analyzed, and 1/9 met primary outcome (11.1%).
They were very sick/ refractory and had failed at least 2 lines of treatment, but what we can see in the results does not fully characterize the depth of their initial conditions. Median OS of 69.5 days or 7 weeks isn't a home run either when compared to a quick search of RECIST refractory BC outcomes. The darker backdrop on this is Marker not announcing the data and slipping it in during the Orphan Designation news. I believe these data have been in the can for nearly a year. I swear I hate conspiracy theory posters, but can somebody please argue the reverse and point out my errors? Loving the share price due to Orphan but TACTIC isn't even a factor. As a lame underwater bag holder and drinker of bad wine, this smells like Two-Buck Chuck next week.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News